For Lab Industry, FDA Draft Guidance on NGS Testing Inseparable From Larger LDT Debate

Jul 11, 2016

|

Premium

NEW YORK (GenomeWeb) – After releasing white papers, holding several public workshops, and listening to stakeholder feedback, the US Food and Drug Administration has released two draft guidances outlining how it might review the analytical and clinical validity of next-generation sequencing tests.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

Who Are You?

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

'Problematic'

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Republicans Take on Peer Review

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

This Week in Science

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.

Featured White Papers

Generating Mouse Models with CRISPR/Cas9

A Method to Streamline and Miniaturize Nextera Library Preparation for Illumina Next-Gen Sequencing Using the Labcyte Echo 525 Liquid Handler

Optimized NGS Library Preparation with Acoustic Liquid Handling

Miniaturizing siRNA Transfection Using the Echo Liquid Handler

Oct

24

Featured Webinar

Measuring More to Guess Less: Comprehensive Immune Profiling for Immunotherapy Selection

This webinar will discuss the advantages of a multiple-biomarker-based approach for immune profiling that provides clinicians with a rational means to consider approved immunotherapies or assign patients to immunotherapy clinical trials.

Nov

02

Featured Webinar

Validation of a UMI-Powered NGS Panel for Improved Variant Calling

This webinar will discuss the benefits of using unique molecular indices to overcome some challenges associated with next-generation sequencing panels.

Nov

09

Featured Webinar

The Neuronal Epigenome: The Role of Non-CpG DNA Methylation in Neurological Disorders

This webinar will discuss the role of a newly discovered, brain-enriched form of non-CpG DNA methylation in neural development and disease.

Dec

05

Featured Webinar

Combined Mutation Detection and Copy Number Profiling by Error-Corrected ctDNA Sequencing

This webinar will discuss a molecular barcode-based error correction method that enables combined mutation detection and DNA copy number profiling through circulating tumor DNA sequencing.

Main menu